2005 Poliovirus eradication: Poliovirus presence in Cyprus 2 years after

Water Science and Technology

Volumn 58, Issue 3, 2008, Pages 647-651

  Richter, Jan ^a   Bashiardes, Stavros ^a   Koptides, Dana ^a   Tryfonos, Christina ^a   Pissarides, Nikolas ^b   Stavrou, Niki ^b   Papageorgiou, Georgos T ^b   Christodoulou, Christina ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b State General Laboratory of Cyprus   (Cyprus)

Author keywords

Polio eradication; Sewage concentration; Vaccine derived poliovirus; Wild type poliovirus

Indexed keywords

SEWAGE;

POLIO ERADICATION; SEWAGE CONCENTRATION; VACCINE-DERIVED POLIOVIRUS; WILD-TYPE POLIOVIRUS;

VACCINES;

ORAL POLIOMYELITIS VACCINE;

CONCENTRATION (COMPOSITION); DISEASE CONTROL; SEWAGE; VACCINE; VIRUS; WORLD HEALTH ORGANIZATION;

ARTICLE; CYPRUS; DRUG EFFICACY; ERADICATION THERAPY; HUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEWAGE TREATMENT; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN;

CYPRUS; ENVIRONMENTAL MONITORING; HUMANS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEWAGE;

ASIA; CYPRUS; EURASIA; MIDDLE EAST;

POLIOVIRUS;

EID: 52949102254     PISSN: 02731223     EISSN: None     Source Type: Book Series    
DOI: 10.2166/wst.2008.425     Document Type: Article

References (20)

1. Cann, A.J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M., Schild, G. C. & Almond, J. W. 1984 Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res. 12, 7787-7792.
2. CDC 2004 Progress toward global eradication of poliomyelitis. January 2003-April. MMWR Morb. Mort. Wkly. Rep., 53, 532-535.
3. Christodoulou, C., Colbere-Garapin, F., Macadam, A., Taffs, L. F., Marsden, S., Minor, P. & Horaud, F. 1990 Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64, 4922-4929.
4. Deshpande, J. M., Shetty, S. J. & Siddiqui, Z. A. 2003 Environmental surveillance system to track wild poliovirus transmission. Appl. Environ. Microbiol. 69, 2919-2927.
5. El-Sageyer, M. M., Szendroi, A., Hutter, E., Uj, M., Szucs, G., Mezey, I., Toth, I., Katai, A., Kapiller, Z., Pall, G., Petras, G., Szalay, E., Mihaly, I., Gourova, S. & Berencsi, G. 1998 Characterisation of an echovirus type 11′ (prime) epidemic strain causing haemorrhagic syndrome in newborn babies in Hungary. Acta Virol. 42, 157-166.
6. Evans, D. M., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K. & Maizel, J. V., Jr 1985 Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314, 548-550.
7. Hull, B. P. & Dowdle, W. R. 1997 Poliovirus surveillance: building the global Polio laboratory network. J. Infect. Dis. 175(Suppl 1), S113-S116.
8. Macadam, A. J., Pollard, S. R., Ferguson, G., Skuce, R., Wood, D., Almond, J. W. & Minor, P. D. 1993 Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 19, 18-26.
9. Manor, Y., Handsher, R., Halmut, T., Neuman, M., Bobrov, A., Rudich, H., Vonsover, A., Shulman, L., Kew, O. & Mendelson, E. 1999 Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J. Clin. Microbiol. 37, 1670-1675.
10. Martinez, C. V., Old, M. O., Kwock, D. K., Khan, S. S., Garcia, J. J., Chan, C. S., Webster, R., Falkovitz-Halpern, M. S. & Maldonado, Y. A. 2004 Shedding of sabin poliovirus type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J. Infect. Dis. 190, 409-416.
11. Oberste, M. S., Maher, K., Kilpatrick, D. R., Flemister, M. R., Brown, B. A. & Pallansch, M. A. 1999 Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37, 1288-1293.
12. Oberste, M. S., Nix, W. A., Maher, K. & Pallansch, M. A. 2003 Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 26, 375-377.
13. Omata, T., Kohara, M., Kuge, S., Komatsu, T., Abe, S., Semler, B. L., Kameda, A., Itoh, H., Arita, M. & Wimmer, E. 1986 Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58, 348-358.
14. Papageorgiou, G. T., Moce-Llivina, L., Christodoulou, C. G., Lucena, F., Akkelidou, D., Ioannou, E. & Jofre, J. 2000 A simple methodological approach for counting and identifying culturable viruses adsorbed to cellulose nitrate membrane filters. Appl. Environ. Microbiol. 66, 194-198.
15. Pollard, S. R., Dunn, G., Cammack, N., Minor, P. D. & Almond, J. W. 1989 Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J. Virol. 63, 4949-4951.
16. Richter, J., Koptides, D., Tryfonos, C. & Christodoulou, C. 2006 Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000-2002. J. Med. Microbiol. 55, 1035-1041.
17. Tambini, G., Andrus, J. K., Marques, E., Boshell, J., Pallansch, M., de Quadros, C. A. & Kew, O. 1993 Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. J. Infect. Dis. 168, 1510-1514.
18. van der Avoort, H. G., Reimerink, I. H., Ras, A., Mulders, M. N. & van Loon, A. M. 1995 Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in The Netherlands. Epidemiol. Infect. 114, 481-491.
19. World Health Assembly 1988 Global eradication of poliomyelitis by the year 2000 Resolution WHA 41.28. Ref Type: Bill/ Resolution.
20. World Health Organization 2003 Global Polio Eradication Initiative Progress 2002. World Health Organization, Geneva, Switzerland.